Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Daily Top 10 COVID-19 papers

DEU | ENG | ESP | FRA | ITA | POR | TUR | VNM


  Arrhythmias

  Free Subscription


11.05.2020

1 Am J Cardiol
1 Ann Emerg Med
1 Circ Arrhythm Electrophysiol
2 Circ Cardiovasc Qual Outcomes
1 Circ Res
2 Circulation
1 Clin Cardiol
3 Eur Heart J
1 Eur J Pharmacol
3 J Am Coll Cardiol
2 J Cardiovasc Electrophysiol
1 J Electrocardiol
2 J Interv Card Electrophysiol
1 J Thromb Thrombolysis
1 Pacing Clin Electrophysiol
2 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Cardiol

  1. YANG L, Brooks MM, Glynn NW, Zhang Y, et al
    Real-World Direct Comparison of the Effectiveness and Safety of Apixaban, Dabigatran, Rivaroxaban, and Warfarin in Medicare Beneficiaries With Atrial Fibrillation.
    Am J Cardiol. 2020 Apr 10. pii: S0002-9149(20)30323.
    PubMed         Abstract available


    Ann Emerg Med

  2. ALLISON RM, Alwood SM
    Man With Dynamic ECG Changes.
    Ann Emerg Med. 2020;75:518-520.
    PubMed        


    Circ Arrhythm Electrophysiol

  3. REDDY VY, Anter E, Rackauskas G, Peichl P, et al
    A Lattice-Tip Focal Ablation Catheter that Toggles Between Radiofrequency and Pulsed Field Energy to Treat Atrial Fibrillation: A First-in-Human Trial.
    Circ Arrhythm Electrophysiol. 2020 May 8. doi: 10.1161/CIRCEP.120.008718.
    PubMed         Abstract available


    Circ Cardiovasc Qual Outcomes

  4. GUO Y, Lane DA, Chen Y, Lip GYH, et al
    Letter by Guo et al Regarding Article, "SUPPORT-AF II: Supporting Use of Anticoagulants Through Provider Profiling of Oral Anticoagulant Therapy for Atrial Fibrillation".
    Circ Cardiovasc Qual Outcomes. 2020 May 7:CIRCOUTCOMES120006635.
    PubMed        

  5. HOQUE L, McManus DD, Kapoor A
    Response by Hoque et al to Letter Regarding Article, "SUPPORT-AF II: Supporting Use of Anticoagulants Through Provider Profiling of Oral Anticoagulant Therapy for Atrial Fibrillation".
    Circ Cardiovasc Qual Outcomes. 2020 May 7:CIRCOUTCOMES120006671.
    PubMed        


    Circ Res

  6. VAN WAGONER DR
    Paracrine Signals Modulate Atrial Epicardial Progenitor Cells and Development of Subepicardial Adiposity and Fibrosis Implications for Atrial Fibrillation.
    Circ Res. 2020;126:1343-1345.
    PubMed        


    Circulation

  7. DELMAR M, Alvarado FJ, Valdivia HH
    Desmosome-Dyad Crosstalk: An Arrhythmogenic Axis in Arrhythmogenic Right Ventricular Cardiomyopathy.
    Circulation. 2020;141:1494-1497.
    PubMed        

  8. SMITH ED, Lakdawala NK, Papoutsidakis N, Aubert G, et al
    Desmoplakin Cardiomyopathy, a Fibrotic and Inflammatory Form of Cardiomyopathy Distinct from Typical Dilated or Arrhythmogenic Right Ventricular Cardiomyopathy.
    Circulation. 2020 May 6. doi: 10.1161/CIRCULATIONAHA.119.044934.
    PubMed         Abstract available


    Clin Cardiol

  9. SCIRIA CT, Maddox TM, Marzec L, Rodwin B, et al
    Switching warfarin to direct oral anticoagulants in atrial fibrillation: Insights from the NCDR PINNACLE registry.
    Clin Cardiol. 2020 May 6. doi: 10.1002/clc.23376.
    PubMed         Abstract available


    Eur Heart J

  10. SUGIYAMA T
    Hip fracture risk in patients with atrial fibrillation receiving oral anticoagulants.
    Eur Heart J. 2020 May 7. pii: 5831946. doi: 10.1093.
    PubMed        

  11. HUANG HK, Yeh JI, Loh CH
    Hip fracture risk in patients with atrial fibrillation receiving oral anticoagulants: a meta-analysis based on current observational studies.
    Eur Heart J. 2020 May 7. pii: 5831944. doi: 10.1093.
    PubMed        

  12. ZABEL M, Willems R, Lubinski A, Bauer A, et al
    Clinical effectiveness of primary prevention implantable cardioverter-defibrillators: results of the EU-CERT-ICD controlled multicentre cohort study.
    Eur Heart J. 2020 May 6. pii: 5830833. doi: 10.1093.
    PubMed         Abstract available


    Eur J Pharmacol

  13. RAHM AK, Muller ME, Gramlich D, Lugenbiel P, et al
    Inhibition of cardiac Kv4.3 (Ito) channel isoforms by class I antiarrhythmic drugs lidocaine and mexiletine.
    Eur J Pharmacol. 2020 Apr 29:173159. doi: 10.1016/j.ejphar.2020.173159.
    PubMed         Abstract available


    J Am Coll Cardiol

  14. ZOGHBI WA
    Should Left Atrial Size Influence the Decision to Intervene in Degenerative Mitral Regurgitation?
    J Am Coll Cardiol. 2019;74:871-873.
    PubMed        

  15. KIM JY, Kim SH
    Reply: Off-Label Use of Direct Oral Anticoagulants in Patients With Mitral Stenosis.
    J Am Coll Cardiol. 2019;73:3362-3363.
    PubMed        

  16. ZHOU Z
    Efficacy and Safety of Direct Oral Anticoagulants in Patients With Mitral Stenosis.
    J Am Coll Cardiol. 2019;73:3362.
    PubMed        


    J Cardiovasc Electrophysiol

  17. KOCHI AN, Tagliari AP, Forleo GB, Fassini GM, et al
    Cardiac and arrhythmic complications in patients with COVID-19.
    J Cardiovasc Electrophysiol. 2020;31:1003-1008.
    PubMed         Abstract available

  18. MASCIA G, Arbelo E, Porto I, Brugada R, et al
    The Arrhythmogenic Right Ventricular Cardiomyopathy in comparison to the athletic heart.
    J Cardiovasc Electrophysiol. 2020 May 4. doi: 10.1111/jce.14526.
    PubMed         Abstract available


    J Electrocardiol

  19. ZHAO Z, Li R, Wang X, Li J, et al
    Suppression of experimental atrial fibrillation in a canine model of rapid atrial pacing by the phosphodiesterase 3 inhibitor cilostazol.
    J Electrocardiol. 2020;60:151-158.
    PubMed         Abstract available


    J Interv Card Electrophysiol

  20. MAO YJ, Wang H, Huang PF
    Meta-analysis of the safety and efficacy of using minimally interrupted novel oral anticoagulants in patients undergoing catheter ablation for atrial fibrillation.
    J Interv Card Electrophysiol. 2020 May 2. pii: 10.1007/s10840-020-00754.
    PubMed         Abstract available

  21. GIUSTOZZI M, Ali H, Reboldi G, Balla C, et al
    Safety of catheter ablation of atrial fibrillation in cancer survivors.
    J Interv Card Electrophysiol. 2020 May 6. pii: 10.1007/s10840-020-00745.
    PubMed         Abstract available


    J Thromb Thrombolysis

  22. DUARTE RCF, Rios DRA, Figueiredo EL, Caiaffa JRS, et al
    Thrombin Generation and other hemostatic parameters in patients with atrial fibrillation in use of warfarin or rivaroxaban.
    J Thromb Thrombolysis. 2020 May 6. pii: 10.1007/s11239-020-02126.
    PubMed         Abstract available


    Pacing Clin Electrophysiol

  23. AULD JP, Thompson EA, Dougherty CM
    Social cognitive intervention following an initial implantable cardioverter defibrillator: Better treatment response for secondary vs. primary prevention.
    Pacing Clin Electrophysiol. 2020 May 4. doi: 10.1111/pace.13929.
    PubMed         Abstract available


    PLoS One

  24. HSIEH YC, Hsieh WH, Li CH, Liao YC, et al
    Ventricular divergence correlates with epicardial wavebreaks and predicts ventricular arrhythmia in isolated rabbit hearts during therapeutic hypothermia.
    PLoS One. 2020;15:e0228818.
    PubMed         Abstract available

  25. FARRAHA M, Lu J, Trivic I, Barry MA, et al
    Development of a sheep model of atrioventricular block for the application of novel therapies.
    PLoS One. 2020;15:e0229092.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Arrhythmias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: